{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T11:08:03Z","timestamp":1761822483785},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Stroke"],"published-print":{"date-parts":[[2002,9]]},"abstract":"<jats:p>\n            <jats:bold>\n              <jats:italic>Background and Purpose\u2014<\/jats:italic>\n            <\/jats:bold>\n            Patients with carotid occlusive disease and stage 2 cerebral hemodynamic failure, characterized by an increased oxygen extraction fraction (OEF) as measured by positron emission tomography (PET) and otherwise known as misery perfusion, have a high risk of cerebral ischemia and subsequent stroke. In clinical practice, the detection of patients with misery perfusion through the use of widely available, noninvasive, and cost-effective modalities such as single-photon emission computed tomography (SPECT) is extremely important.\n          <\/jats:p>\n          <jats:p>\n            <jats:bold>\n              <jats:italic>Methods\u2014<\/jats:italic>\n            <\/jats:bold>\n            We evaluated the relationships between the regional hemodynamic status of cerebral circulation, measured with split-dose [\n            <jats:sup>123<\/jats:sup>\n            I]\n            <jats:italic>N<\/jats:italic>\n            -isopropyl-p-iodoamphetamine SPECT (\n            <jats:sup>123<\/jats:sup>\n            I-IMP SPECT) and an acetazolamide challenge, and hemodynamic parameters, including OEF measured with PET, in 27 patients with both unilateral and bilateral carotid occlusive diseases.\n          <\/jats:p>\n          <jats:p>\n            <jats:bold>\n              <jats:italic>Results\u2014<\/jats:italic>\n            <\/jats:bold>\n            A significant negative correlation was found between the SPECT-measured cerebrovascular reserve after acetazolamide administration and both the PET-measured OEF and cerebral blood volume. Neither the cerebrovascular reserve nor the cerebral blood flow index, when expressed as a SPECT-measured cerebrum-to-cerebellum ratio, was useful for detecting lesions with an elevated OEF. However, a combination of the cerebrovascular reserve and cerebral blood flow index showed high sensitivity, specificity, and positive predictive value for the detection of misery perfusion.\n          <\/jats:p>\n          <jats:p>\n            <jats:bold>\n              <jats:italic>Conclusions\u2014<\/jats:italic>\n            <\/jats:bold>\n            Our study suggests that split-dose\n            <jats:sup>123<\/jats:sup>\n            I-IMP SPECT with an acetazolamide challenge could be useful for screening patients with misery perfusion in carotid occlusive diseases.\n          <\/jats:p>","DOI":"10.1161\/01.str.0000027638.19392.7e","type":"journal-article","created":{"date-parts":[[2002,9,5]],"date-time":"2002-09-05T21:22:30Z","timestamp":1031260950000},"page":"2217-2223","update-policy":"http:\/\/dx.doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":46,"title":["Detection of Misery Perfusion With Split-Dose\n            <sup>123<\/sup>\n            I-Iodoamphetamine Single-Photon Emission Computed Tomography in Patients With Carotid Occlusive Diseases"],"prefix":"10.1161","volume":"33","author":[{"given":"Masao","family":"Imaizumi","sequence":"first","affiliation":[{"name":"From the Division of Tracer Kinetics (M.I., N.O., T.T., P.R., T.N.) the Department of Internal Medicine and Therapeutics (K.K., K.H., M.T., T.Y., T.O., M.H., M.M.), Osaka University Graduate School of Medicine, Suita, Osaka, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuo","family":"Kitagawa","sequence":"additional","affiliation":[{"name":"From the Division of Tracer Kinetics (M.I., N.O., T.T., P.R., T.N.) the Department of Internal Medicine and Therapeutics (K.K., K.H., M.T., T.Y., T.O., M.H., M.M.), Osaka University Graduate School of Medicine, Suita, Osaka, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuo","family":"Hashikawa","sequence":"additional","affiliation":[{"name":"From the Division of Tracer Kinetics (M.I., N.O., T.T., P.R., T.N.) the Department of Internal Medicine and Therapeutics (K.K., K.H., M.T., T.Y., T.O., M.H., M.M.), Osaka University Graduate School of Medicine, Suita, Osaka, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naohiko","family":"Oku","sequence":"additional","affiliation":[{"name":"From the Division of Tracer Kinetics (M.I., N.O., T.T., P.R., T.N.) the Department of Internal Medicine and Therapeutics (K.K., K.H., M.T., T.Y., T.O., M.H., M.M.), Osaka University Graduate School of Medicine, Suita, Osaka, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadamasa","family":"Teratani","sequence":"additional","affiliation":[{"name":"From the Division of Tracer Kinetics (M.I., N.O., T.T., P.R., T.N.) the Department of Internal Medicine and Therapeutics (K.K., K.H., M.T., T.Y., T.O., M.H., M.M.), Osaka University Graduate School of Medicine, Suita, Osaka, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masashi","family":"Takasawa","sequence":"additional","affiliation":[{"name":"From the Division of Tracer Kinetics (M.I., N.O., T.T., P.R., T.N.) the Department of Internal Medicine and Therapeutics (K.K., K.H., M.T., T.Y., T.O., M.H., M.M.), Osaka University Graduate School of Medicine, Suita, Osaka, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuya","family":"Yoshikawa","sequence":"additional","affiliation":[{"name":"From the Division of Tracer Kinetics (M.I., N.O., T.T., P.R., T.N.) the Department of Internal Medicine and Therapeutics (K.K., K.H., M.T., T.Y., T.O., M.H., M.M.), Osaka University Graduate School of Medicine, Suita, Osaka, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piao","family":"Rishu","sequence":"additional","affiliation":[{"name":"From the Division of Tracer Kinetics (M.I., N.O., T.T., P.R., T.N.) the Department of Internal Medicine and Therapeutics (K.K., K.H., M.T., T.Y., T.O., M.H., M.M.), Osaka University Graduate School of Medicine, Suita, Osaka, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiho","family":"Ohtsuki","sequence":"additional","affiliation":[{"name":"From the Division of Tracer Kinetics (M.I., N.O., T.T., P.R., T.N.) the Department of Internal Medicine and Therapeutics (K.K., K.H., M.T., T.Y., T.O., M.H., M.M.), Osaka University Graduate School of Medicine, Suita, Osaka, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masatsugu","family":"Hori","sequence":"additional","affiliation":[{"name":"From the Division of Tracer Kinetics (M.I., N.O., T.T., P.R., T.N.) the Department of Internal Medicine and Therapeutics (K.K., K.H., M.T., T.Y., T.O., M.H., M.M.), Osaka University Graduate School of Medicine, Suita, Osaka, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayasu","family":"Matsumoto","sequence":"additional","affiliation":[{"name":"From the Division of Tracer Kinetics (M.I., N.O., T.T., P.R., T.N.) the Department of Internal Medicine and Therapeutics (K.K., K.H., M.T., T.Y., T.O., M.H., M.M.), Osaka University Graduate School of Medicine, Suita, Osaka, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsunehiko","family":"Nishimura","sequence":"additional","affiliation":[{"name":"From the Division of Tracer Kinetics (M.I., N.O., T.T., P.R., T.N.) the Department of Internal Medicine and Therapeutics (K.K., K.H., M.T., T.Y., T.O., M.H., M.M.), Osaka University Graduate School of Medicine, Suita, Osaka, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"e_1_3_2_1_2","doi-asserted-by":"publisher","DOI":"10.3171\/jns.1993.79.4.0483"},{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.280.12.1055"},{"key":"e_1_3_2_3_2","first-page":"1992","volume":"40","year":"1999","unstructured":"Yamauchi H, Fukuyama H, Nagahama Y, Nabatame H, Ueno M, Nishizawa S, Konishi J, Shio H. Significance of increased oxygen extraction fraction in five-year prognosis of major cerebral arterial occlusive diseases. J Nucl Med. 1999; 40: 1992\u20131998.","journal-title":"J Nucl Med"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-106-1-27"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1161\/str.12.4.6976022"},{"key":"e_1_3_2_6_2","first-page":"1226","volume":"35","year":"1994","unstructured":"Hashikawa K, Matsumoto M, Moriwaki H, Oku N, Okazaki Y, Uehara T, Handa N, Kusuoka H, Kamada T, Nishimura T. Split dose iodine-123-IMP SPECT: sequential quantitative regional cerebral blood flow change with pharmacological intervention. J Nucl Med. 1994; 35: 1226\u20131233.","journal-title":"J Nucl Med"},{"key":"e_1_3_2_7_2","first-page":"279.","volume":"38","year":"1997","unstructured":"Hashikawa K, Matsumoto M, Moriwaki H, Oku N, Seike Y, Sakaguchi M, Sugimoto K, Nishimura H, Fukuchi K, Watanabe Y, Uehara T, Hori M, Nishimura T. Non-invasive measurement of cerebral perfusion reserve, split dose I-123 IMP SPECT method: the validation with O-15 H2O PET method. J Nucl Med. 1997; 38: 279.Abstract.","journal-title":"J Nucl Med"},{"key":"e_1_3_2_8_2","first-page":"227","volume":"8","year":"1998","unstructured":"Kanno I, Uemura K, Higano S, Murakami M, Iida H, Miura S, Shishido F, Inugami A, Sayama I. Oxygen extraction fraction at maximally vasodilated tissue in the ischemic brain estimated from the regional CO2 responsiveness measured by positron emission tomography. J Cereb Blood Flow Metab. 1998; 8: 227\u2013235.","journal-title":"J Cereb Blood Flow Metab"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.51.8.1045"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1038\/jcbfm.1994.97"},{"key":"e_1_3_2_11_2","first-page":"563","volume":"16","year":"1995","unstructured":"Nariai T, Suzuki R, Hirakawa K, Maehara T, Ishii K, Senda M. Vascular reserve in chronic cerebral ischemia measured by the acetazolamide challenge test: comparison with positron emission tomography. AJNR Am J Neuroradiol. 1995; 16: 563\u2013570.","journal-title":"AJNR Am J Neuroradiol"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1161\/str.22.6.2057968"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1161\/str.21.4.2326846"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1748-1716.1983.tb07202.x"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1161\/str.18.2.3564109"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1161\/str.27.11.2052"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004647-199809000-00005"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004647-200112000-00012"},{"key":"e_1_3_2_19_2","unstructured":"Hayashida K Hirose Y Tanaka Y. Stratification of severity by cerebral blood flow oxygen metabolism and acetazolamide reactivity in patients with cerebrovascular disease. In: Ishii Y ed. Recent Advances in Biomedical Imaging. Amsterdam Netherlands: Elsevier; 1997: 113\u2013119."},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1161\/str.21.10.2219203"},{"key":"e_1_3_2_21_2","first-page":"1556","volume":"38","year":"1997","unstructured":"Moriwaki H, Matsumoto M, Hashikawa K, Oku N, Ishida M, Seike Y, Watanabe Y, Hougaku H, Handa N, Nishimura T. Hemodynamic aspect of cerebral watershed infarction: assessment of perfusion reserve using iodine-123-iodoamphetamine SPECT. J Nucl Med. 1997; 38: 1556\u20131562.","journal-title":"J Nucl Med"},{"key":"e_1_3_2_22_2","first-page":"1348","volume":"39","year":"1998","unstructured":"Moriwaki H, Matsumoto M, Hashikawa K, Oku N, Ishida M, Seike Y, Fukuchi K, Hori M, Nishimura T. Iodine-123-iomazenil and iodine-123-iodoamphetamine SPECT in major cerebral artery occlusive disease. J Nucl Med. 1998; 39: 1348\u20131353.","journal-title":"J Nucl Med"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410290302"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.53.2.251"}],"container-title":["Stroke"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/01.STR.0000027638.19392.7E","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,12]],"date-time":"2024-05-12T20:49:09Z","timestamp":1715546949000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/01.STR.0000027638.19392.7E"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,9]]},"references-count":24,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2002,9]]}},"alternative-id":["10.1161\/01.STR.0000027638.19392.7E"],"URL":"https:\/\/doi.org\/10.1161\/01.str.0000027638.19392.7e","relation":{},"ISSN":["0039-2499","1524-4628"],"issn-type":[{"value":"0039-2499","type":"print"},{"value":"1524-4628","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,9]]},"assertion":[{"value":"2002-03-18","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2002-05-07","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2002-09-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}